A synthetic fragment of Thymosin Beta-4 that regulates actin, promotes cell migration to injury sites, and reduces inflammation — commonly stacked with BPC-157 for accelerated recovery.
| Provider | Type | Price | Review | Link |
|---|---|---|---|---|
| Defy Medical | Telehealth | ~$200/mo | Read review | Get Started → |
| Marek Health | Telehealth | $166/mo | Read review | Get Started → |
| NextGenPeps | Research | $54 / 10mg | — | Visit Site → |
Telehealth = physician-prescribed. Research = for research use only, no prescription required. Learn the difference →
TB-500 is a synthetic analogue of the active region of Thymosin Beta-4 — a naturally occurring peptide found in high concentrations at injury sites throughout the body. Thymosin Beta-4 plays a central role in actin regulation, which governs cell shape, movement, and division. TB-500 mimics this activity, directing stem cells and other repair-capable cells toward areas of damage.
TB-500 acts by sequestering G-actin and promoting actin polymerization in damaged tissue, which enables faster cell migration to wound sites. It also downregulates inflammatory cytokines and upregulates anti-inflammatory signals. In animal models, TB-500 has been shown to accelerate wound closure, tendon healing, and cardiac tissue repair after injury.
These two peptides are frequently used together because they work through complementary mechanisms. BPC-157 is particularly potent for tendon, ligament, and gut healing through angiogenesis and growth factor modulation, while TB-500 excels at systemic cell migration and inflammation control. Together they represent the most comprehensive peptide recovery stack available.
Use code 3LUIZH10 at NextGenPeps for a discount on research-grade TB-500.